Try our beta test site
2 studies found for:    20072077 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Long-Term Antibody Persistence at 1, 3 and 5 Years After a Fourth Dose of GSK Biologicals' Hib-MenCY-TT Vaccine Compared to ActHIB
Conditions: Neisseria Meningitidis;   Haemophilus Influenzae Type b
Interventions: Biological: MenHibrix (Hib-MenCY-TT);   Biological: Hib conjugate vaccine (ActHIB)
2 Completed
Has Results
Comparison of GSKBiologicals' Hib-MenCY-TT Vaccine vs Licensed Hib Conjugate or Meningococcal Vaccine
Conditions: Haemophilus Influenzae Type b;   Neisseria Meningitidis
Interventions: Biological: GSK Biologicals' Haemophilus influenza type b and Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine 792014 vaccine;   Biological: ActHIB;   Biological: Pediarix;   Biological: Prevnar;   Biological: Menomune

Study has passed its completion date and status has not been verified in more than two years.